| Period Ending | Mar 30, 2004 |
|---|
|
Total Revenue
|
7,728
| | Cost of Revenue | 4,617 | | |
Gross Profit
|
3,111
| |
|
Operating Expenses |
|
Research Development |
-
|
|
Selling General and Administrative | 152 |
|
Non Recurring |
-
|
|
Others | 1,378 |
|
|
|
Total Operating Expenses |
-
| | | |
Operating Income or Loss
|
1,581
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 77 |
|
Earnings Before Interest And Taxes | 1,658 |
|
Interest Expense | 414 |
|
Income Before Tax | 1,244 |
|
Income Tax Expense |
-
|
|
Minority Interest |
-
|
|
|
|
Net Income From Continuing Ops | 1,244 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | | |
Net Income
|
1,244
| | Preferred Stock And Other Adjustments |
-
| | |
Net Income Applicable To Common Shares
|
1,244
|
|
0.14(9.03%) May 22 - Nasdaq Real Time Price